Category: Pharmaceutical Law & Policy
Prior Authorization for Generic Alternatives: A Pharmacist’s Guide to Navigating Insurance Policies
Navigating prior authorization for generic alternatives is a major challenge for pharmacists. Learn how step therapy works, why denials happen, and proven strategies to speed up approvals across major insurers.
How the Pandemic Disrupted Drug Supply Chains and Sparked a Dual Crisis
Explore how the COVID-19 pandemic caused severe drug shortages and fueled the opioid crisis. Learn about supply chain failures, telehealth shifts, and lasting impacts on medication access.
FDA List of Authorized Generics: Where to Find Information and How to Use It
Find the official FDA list of authorized generics, learn how it differs from the Orange Book, and discover how to verify current drug availability using practical steps.
Medicaid Generic Policies: How States Control Prescription Drug Costs
Explore how states use Medicaid generic policies like MAC lists and MDRP rebates to control rising prescription drug costs while managing supply chain risks.
How to Understand Boxed Warning Label Changes Over Time: A Guide for Healthcare Professionals
Learn how to track and interpret FDA boxed warning label changes, understand the reasons behind updates, and apply this knowledge to improve patient safety in clinical practice.
Understanding the Hatch-Waxman Act: How US Generic Drug Policy Works
Explore how the Hatch-Waxman Act balances drug innovation with generic competition, shaping the US pharmaceutical market and FDA approval processes.